W e reviewed research on retinal oxygen (O 2 ) distribution and use, focusing on O 2 microelectrode studies in animals with circulatory patterns similar to those of humans. The inner and outer halves of the retina are different domains in terms of O 2 . Understanding their properties can suggest mechanisms of and therapies for retinal diseases. Inner retinal PO 2 averages about 20 mm Hg. Effective O 2 autoregulation of the retinal circulation ensures that inner retinal PO 2 is relatively uninfluenced by systemic hypoxia and hyperoxia and increased intraocular pressure in healthy animals. Failures of the retinal circulation lead to tissue hypoxia that underlies the vasoproliferation in diabetic retinopathy and retinopathy of prematurity. Choroidal blood flow is not regulated metabolically, so systemic hypoxia and elevated intraocular pressure lead to decreases in choroidal PO 2 and photoreceptor O 2 consumption. The same lack of regulation allows choroidal PO 2 to increase dramatically during hyperoxia, offering the potential for O 2 to be used therapeutically in retinal vascular occlusive diseases and retinal detachment.
Oxygen (O 2 ) is essential for retinal function. As in other tissues, O 2 diffuses through the tissue passively from the circulation and is consumed in the oxidative production of adenosine triphosphate. However, several features make retinal oxygenation unique, and these have an impact on the pathogenesis and treatment of retinal diseases. Among the unique features influencing retinal oxygenation are the presence of a dual circulation, lack of metabolic regulation of the choroid, presence of O 2 regulation of the retinal circulation, and localization of mitochondria to photoreceptor inner segments. In most cases, it is useful to think of the retina as the following 2 domains: the avascular outer retina and the vascularized inner retina. The retina is also one of the most metabolically active tissues, consuming O 2 more rapidly than many other tissues, 1 including the brain. 2, 3 Because the demand for O 2 is high, and because it cannot be stored in the retina or other tissues, a continuous O 2 supply is essential. 4 This review focuses on vascularized retinas (eg, of the rat, cat, pig, monkey, and human) in which O 2 is delivered by the retinal and choroidal circulations. In some species, retinal vasculature is nearly or completely absent (eg, the rabbit and guinea pig). These retinas rely on the choroid almost exclusively and the inner retina is strongly glycolytic. [5] [6] [7] A review focusing on avascular and partially vascularized retina has been presented elsewhere. 8 Retinal O 2 tension (PO 2 ) and other variables that provide an index of PO 2 have been measured in several ways, which have recently been presented by Hogeboom van Buggenum et al. 9 Hemoglobin saturation in retinal vessels has been measured by several groups. [10] [11] [12] Intravascular PO 2 has been measured with a phosphorescent dye, for which decay is inversely proportional to the PO 2 . 13 Berkowitz and coworkers 14, 15 have pioneered the development of magnetic resonance imaging techniques that measure absolute PO 2 in the preretinal vit-reous of animals and humans using the fluorine signal from perfluorocarbon droplets. They have also measured relative PO 2 by using the dependence of the hydrogen signal on O 2 . 16 However, only oxygen microelectrodes [17] [18] [19] [20] have been able to map out O 2 gradients within the retina with high spatial and temporal resolution. We will focus on these measurements in the first part of this review. In some of this work, a second barrel of the electrode has been used to record the local electroretinogram (ERG) and the transepithelial potential across the retinal pigment epithelium, which allows verification of the position of the intraretinal electrode. 21, 22 The invasive nature of the microelectrode is the major disadvantage of this technique, because the electrode may damage the tissue during measurement. Hence, this technique has limited clinical application. To date, microelectrodes have only been used in humans to measure O 2 in the vitreous during intraocular surgery. 23, 24 Some authors have argued that O 2 consumption by the microelectrode itself is another disadvantage. 12 However, small recessed cathode microelectrodes 17, 20 do not significantly disturb the local O 2 environment. 25 Microelectrode O 2 consumption (QO 2 ) is about the same as that of a single small cell. An electrode producing a current of 2 pA, which is typical in our work, uses 5.2ϫ 10 −16 mol of O 2 per second. This is the same as the O 2 use of a 6.2-µm cube of tissue in a region with a modest QO 2 of 3 mL O 2 per 100 g of tissue per minute.
Oxygen recordings of the type presented herein are obtained as shown in Figure 1 . The microelectrode is advanced with a microdrive through the retina in dis-crete (eg, 3-µm) steps until it reaches the choroid. The electrode is then withdrawn continuously, usually at a constant speed of 2 µm/s in our work. The map of PO 2 across the retina, an O 2 profile, can be recorded during microelectrode penetration or withdrawal, and these give similar results. Data obtained during withdrawals are preferable because one can be sure that the tissue and vasculature are not being compressed, and because a larger number of data points can be recorded than during penetration. In other experiments, the microelectrode has been left stationary at a point in the retina or vitreous to study responses to light, 22, 26 effects of altered inspired gases, [27] [28] [29] [30] and spontaneous fluctuations in retinal PO 2 . 31
THE NORMAL O 2 PROFILE IN LIGHT AND DARK

Outer Retina
In vivo O 2 profiles have been recorded from pigs, 21, 32 cats, 22, 33 rats, 34 and monkeys. 35 These studies have shown similar O 2 profiles everywhere except in the monkey fovea. Under light-adapted conditions (ie, enough light to saturate rod responses), the PO 2 falls steeply between the choriocapillaris (approximately 60 mm Hg) and the photoreceptor inner segments and subsequently decreases more gradually through the outer retina, as shown in Figure 2 . The direction of this gradient indicates that all of the O 2 used by the photoreceptors comes from the choroid under light-adapted conditions. In darkness, the PO 2 in the outer retina is considerably lower, 22, 35 reaching 0 mm Hg at the proximal side of the inner segments. Sometimes much of the outer nuclear layer in the cat has a PO 2 of 0 mm Hg ( Figure 2 ). This low value leads to a reversal of the gradient of O 2 proximal to the inner segment, so that in darkness, O 2 also diffuses from the retinal circulation to the photoreceptors.
The steep drop of PO 2 from the choroid reflects the high rate of O 2 use by the photoreceptors. 36, 37 The high choroidal PO 2 is maintained by the unusually high flow rate in the choroidal circulation, [38] [39] [40] 20 and inserted into the vitreous through a 15-gauge needle mounted onto a manipulator that allows gonioscopic motion. A boot system is installed to maintain intraocular pressure and to prevent vitreal leakage. The microelectrode is then connected to a microdrive that controls movement in and out of the retina. One barrel, filled with isotonic sodium chloride solution and connected to an amplifier via a silver/silver chloride (Ag/AgCl) wire, measures voltages generated in the retina (the intraretinal electroretinogram and the transepithelial potential across the retinal pigment epithelium). The copper wire from the other barrel is connected to a polarizing voltage (−0.7 V) and a picoammeter to measure currents proportional to PO 2 . 
Inner Retina
One or more O 2 peaks appear in the inner retina ( Figure  2 ). These indicate O 2 sources and, therefore, the presence of nearby retinal vessels. The preretinal PO 2 in the vitreous is normally a good indicator of inner retinal PO 2 , 42,43 because the vitreous consumes very little O 2 , 44 and the inner retina is the source of vitreal O 2 . 43, 44 The average PO 2 in the inner retina of the cat during dark adaptation was 18.5 mm Hg, 45 which is in good agreement with the preretinal PO 2 in cats of 18.9, 28 20 to 30, 44 15 to 20, 42 20.2, 33 and 19 mm Hg. 46 The similarity of retinal and vitreal PO 2 may break down under some conditions, however, including diabetes mellitus. 47 The values of inner retinal PO 2 cover a relatively wide range (Figure 3 ). The average PO 2 is a few millimeters of mercury lower in light adaptation. 22, 45 The O 2 extraction from the retinal circulation is high relative to that in many tissues, about 8 mL O 2 per 100 mL blood, 10 resulting in a low venous PO 2 that contributes to making the average tissue PO 2 in the retina lower than in many organs. 48 
OXYGEN METABOLISM
Oxygen consumption can be derived from material balances in vivo from blood arteriovenous differences 49, 50 or in vitro from reductions in PO 2 in a closed chamber. 3, 51, 52 Oxygen consumption can also be obtained by fitting mathematical models of O 2 diffusion and consumption to PO 2 profiles. 22, 26, 53 The use of material balances does not provide information on the spatial distribution of consumption, but was the first method to show that QO 2 was higher during dark than light adaptation in the whole retina. 52, 54 Further aspects of retinal energy metabolism, particularly the unusual amount of glycolytic metabolism, have been reviewed recently. 3, 55 
Outer Retina
Absolute values of photoreceptor QO 2 were computed by fitting a mathematical model of O 2 diffusion in the outer retina to the O 2 profiles. 53 In the most satisfactory model, all the O 2 use is confined to the inner segment layer. It is important to realize that even though QO 2 is negligible in the outer segment and outer nuclear layers, linear gradients of O 2 still remain throughout these regions ( Figure 5 ). The evidence of a nonzero QO 2 is not the presence of a gradient but curvature in the profile, specifically a quadratic dependence of PO 2 on distance. 53 The Table shows that QO 2 of the photoreceptors during steady illumination is 36% to 68% of the value in the dark. This agrees with the effect of light found by other methods in the rat, rabbit, and pig. 6, 56, 58 Above rod saturation, which is below-normal room illumination, no further changes in QO 2 are observed in the rod-dominated area centralis of the cat retina. 22 Modeling also shows that the choroid is essential to photoreceptor metabolism, contributing approximately 90% of the O 2 consumed by the photoreceptors in darkness, and all of the O 2 consumed during light adaptation. 45 Finally, the choroid contributes approximately 50% of the O 2 consumed by the whole retina in dark adaptation, 26, 56 which is consistent with earlier estimates based on choroidal arteriovenous O 2 differences and blood flow. 39 The Table gives values for QO 2 as though the consumption were uniform across the whole outer retina. We have preferred to report the values this way, because it reduces the scatter in the measurements 53 and makes values from modeling more comparable to those obtained by other methods. These values are somewhat misleading, however, since the QO 2 is localized to the inner segments. The rod inner segments have an extremely high QO 2 of 15 to 20 mL O 2 (standard temperature and pressure) per 100 g of tissue per minute in the dark, consistent with the high density of mitochondria in this region.
Little is known about cone QO 2 . Light does decrease the QO 2 of monkey fovea. 35 Cones in the monkey have a volume of mitochondria that is about 10 times that of rods, 59 but we have argued that QO 2 of an individual cone could not be higher than that of a rod by a factor of 10, because the smaller number of mitochondria in rods already uses all the O 2 available from the circulation.
Oxygen is used in photoreceptors for many processes, but the ones that appear to require the most energy are maintenance of the dark current, ie, pumping out the large load of sodium ion that enters through the light-dependent channels 54, 60, 61 and generating guanosine triphosphate, from which cyclic guanosine monophosphate is produced. 3, 61 The dark current decreases dramatically during illumination, whereas the guanosine triphosphate turnover increases. These appear to be the only processes whose metabolic demands change significantly with illumination. 61 The change in sodium ion pumping is larger, however, and, as a result, illumination causes a net decrease in photoreceptor QO 2 in all species investigated to date.
Inner Retina
In the inner retina, the retinal circulation forms a 3-dimensional mesh, which makes mathematical modeling difficult. The retinal circulation must be occluded to allow the application of a diffusion model to the inner retina. 26, 62 Despite this limitation, various lines of evidence indicate that in the inner retina, no difference in QO 2 exists between darkness and steady illumination 26, 56, 63 (Table) . The metabolism of the inner retina is higher when flickered light (4 Hz) is applied as opposed to steady light, 63 presumably because flickered light leads to greater neural activation. Unfortunately, this increase is difficult to quantify.
RETINAL OXYGENATION UNDER
ALTERED CONDITIONS Hypoxemia Figure 3 shows intraretinal O 2 profiles from the darkadapted cat retina during normoxia and hypoxemia, induced by adding nitrogen to the inspired gas. In the inner retina, tissue PO 2 is effectively regulated across a wide range of PaO 2 . The decrease in preretinal PO 2 is only 0.14 to 0.18 mm Hg/mm Hg PaO 2 when the PaO 2 is above 35 mm Hg 28, 64 in the cat, and 0.2 mm Hg/mm Hg PaO 2 in the miniature pig. 65 When the PaO 2 falls below 35 mm Hg, PO 2 in the inner retina decreases more steeply, approximately 0.62 mm Hg/mm Hg PaO 2 . 64 The good regulation at PaO 2 of greater than 35 mm Hg results from vasodilation of the retinal circulation, 66, 67 which in cats can increase blood flow by more than a factor of 3 during hypoxemia. 68 In the outer retina, hypoxemia leads to a steep decrease in choroidal PO 2 (Figure 4 ) of approximately 0.64 mm Hg/mm Hg PaO 2 . 45 This occurs because the choroidal blood flow does not increase in hypoxemia 69 (Melissa Pulfer, Jameel Ahmed, PhD, and R.A.L., unpublished data, June 2000). There would be little advantage of increasing choroidal blood flow, even if this were possible. The usual advantage of increasing blood flow to a tissue during hypoxemia is allowing the arteriovenous O 2 difference to be reduced, which minimizes or prevents a decrease in venous PO 2 during hypoxemia. In the choroid, the arteriovenous O 2 difference is already very small, only about 1 volume percent, 28 due to the high rate of blood flow. In relatively mild hypoxemia, arterial PO 2 drops below the normoxic choroidal venous PO 2 . Reducing the arteriovenous difference could not prevent this. Because photoreceptor metabolism is O 2 limited under normoxic conditions in darkness, even mild hypoxemia (PaO 2 of 60 mm Hg) reduces the flux of O 2 to the inner segments and, therefore, reduces photoreceptor QO 2 . 45 When hypoxemia occurs during light adaptation, choroidal PO 2 also falls, but in this case, metabolism is not O 2 limited, so photoreceptor QO 2 is not affected.
Elevated Intraocular Pressure
When the intraocular pressure (IOP) is elevated, the effects on retinal PO 2 are similar to those observed during hypoxemia. 70, 71 Decreased perfusion pressure does not affect PO 2 in the inner retina owing to effective autoregulation in the retinal circulation. 39, 72, 73 In contrast, when the IOP is elevated, the choroidal blood flow decreases, 72, [74] [75] [76] which leads to a reduction of choroidal PO 2 of approximately 0.5 mm Hg/mm Hg of perfusion pressure. 70 This reduction leads to a reduction in photoreceptor QO 2 . 70 An extension of this finding is that anything that decreases choroidal blood flow would be expected to have a negative impact on retinal oxygenation and on photoreceptors. There is evidence that human and experimental glaucomas affect photoreceptors, 77 possibly because they reduce photoreceptor O 2 supply, and there is direct evidence of retinal damage by reduced choroidal blood flow in birds. 78 Hyperoxia Figure 5 compares a normoxic profile to one obtained during hyperoxia (inspiration of 100% O 2 ). Vitreal PO 2 28 and inner retinal PO 2 29,30,32,57,79 are well regulated during hyperoxia in the cat, pig, and rat and presumably in humans. This regulation is due to constriction of retinal vessels 10,66,80 and reduction of retinal blood flow. 10, 66, 81 In the miniature pig, PO 2 in the inner retina has been reported to be perfectly regulated during hyperoxia in intervascular zones, 29, 32 but it increases by an average of approximately 40 mm Hg in juxta-arteriolar zones, the same value observed in cats. 30, 57 Adding 5% carbon dioxide to the inspired gas leads to larger increases in inner retinal PO 2 during hyperoxia. 16 The most striking change during hyperoxia is the increase in choroidal PO 2 to about 250 mm Hg in cats 30 and 220 mm Hg in miniature pigs. 32 This increase is a consequence of the lack of metabolic regulation of choroidal blood flow. 82 It is sometimes thought that hyperoxic therapy has a limited potential for treating retinal disease. This is based on the idea that the blood is nearly saturated with O 2 during normoxia, so that the small additional O 2 content during hyperoxia should be of little benefit. The fundamental misconception is that the O 2 supply to the tissue relies on O 2 saturation, whereas, in reality, O 2 moves into tissue by simple diffusion, which is driven by gradients of PO 2 , not saturation. The PO 2 gradient from the choroid is much steeper during hyperoxia, and a greater portion of the retina can be supplied by the choroid during hyperoxia than during normoxia, 30, 32 as shown in Figure 5 .
Despite an abundance of O 2 , higher photoreceptor QO 2 was not found in cat retina during hyperoxia. 30, 57 Pournaras and coworkers 32, 83 argued that QO 2 increased during hyperoxia in healthy retinas of the miniature pig, but not in retinas with a branch vein occlusion. Their conclusions were not based on calculations of QO 2 , however, but only on the steepness of gradients, which cannot be used to infer values for QO 2 . The gradient through the outer segments is steeper during hyperoxia, so the flux across them is larger, but they never use any O 2 .
For a few hours, at least, hyperoxia does not impair retinal electrical function in animals, 57 but the issue of O 2 toxicity to the retina has not been fully addressed. It is clear that O 2 can be damaging to photoreceptors if combined with high levels of illumination. 84, 85 
CLINICAL ISSUES
Diabetic Retinopathy
Diabetic retinopathy is a disease predominantly of the retinal vasculature, leading first to capillary occlusion and then to vascular proliferation. For many years, tissue hypoxia has been suggested to be involved in the progres-sion of diabetic retinopathy 86 and retinal neovascularization in general. 87 By the time that capillary nonperfusion is clinically observable, tissue hypoxia has likely occurred, but the exact time when hypoxia begins is as yet unknown. Retinal tissue hypoxia was not found in the early stage of diabetic retinopathy in animal models. 46, 88, 89 However, intraretinal O 2 measurements on cats with long-term (6-7 years) diabetes mellitus showed an abnormally low average inner retinal PO 2 of 7.7 mm Hg (compared with 16.4 mm Hg in normal cats). 47 This report, the only one to provide intraretinal measurements, stressed that tissue hypoxia was present in the diabetic retina before capillary dropout was evident and when only a few microaneurysms were present. Further evidence of hypoxia relatively early in the disease was provided by the observation that hyperoxia reversed early contrast sensitivity deficits 90 and oscillatory potential reductions. 91 In addition, Arden et al 92 provided evidence of altered dark adaptation in diabetes mellitus, which was also suggested to be an effect of hypoxia.
Hypoxia may occur during diabetic retinopathy due to capillary occlusion. Leukocytes have been reported to be present in greater number and are less deformable in diabetic cats. 93 Increased levels of endothelial cell/ leukocyte adhesion molecules (intercellular adhesion molecule 1 and P-selectin) have also been observed in humans with diabetes mellitus (hereafter referred to as diabetic humans). 94 These findings may explain the increase of leukocyte activation and adhesion in diabetic humans 95 and rats, 96 which are known to increase vascular resistance 97, 98 as capillaries become plugged. In addition, a hyperglycemic (hyperosmotic) environment increases the adhesion of leukocytes to retinal endothelial cells. 99 The findings of tissue hypoxia and occlusion of retinal capillaries by leukocytes are consistent with observations that retinal blood flow is reduced before and in the early stages of diabetic retinopathy. [100] [101] [102] [103] A subsequent increase in retinal blood flow occurs, 102,103 possibly because lower-resistance shunt pathways develop and carry some of the flow 102 and/or because vascular endothelial growth factor (VEGF) dilates vessels. 103 The flow is reduced again in proliferative retinopathy. 104, 105 Complete consensus on this sequence of events has not been achieved, but they seem to explain most of the observations.
One of the puzzles about diabetic retinopathy has always been why it affects the microvasculature of the retina more than that of the brain. 106 Arden et al 92 suggested that dark adaptation aggravates hypoxia by depriving the inner retina of the small amount of O 2 that diffuses from the choroid during light adaptation. They suggested further that avoiding a long period of dark adaptation (eg, during sleeping at night) could be an alternative therapy for diabetic retinopathy.
Hypoxia is thought to induce the synthesis of VEGF, 107, 108 which is present in higher levels during proliferative diabetic retinopathy. 109, 110 Vascular endothelial growth factor has also been found in eyes with no retinopathy or only early signs of retinopathy. [111] [112] [113] This initially suggested that factors besides hypoxia may induce the production of VEGF, 112 but we now know that the retina is hypoxic early in the disease. 47 Although VEGF (REPRINTED) ARCH OPHTHALMOL / VOL 121, APR 2003 is important, other angiogenic [114] [115] [116] [117] [118] and antiangiogenic 119, 120 factors may also be involved. A detailed discussion on factors involved in intraocular neovascularization is available elsewhere. 121 A competing theory of vasoproliferation implicated the mechanical aspect of vasodilation resulting from hypoxia or hyperglycemia. 122 This theory has received little attention recently, but it seems prudent to recognize that mechanical factors could play a role in angiogenesis.
The QO 2 of the retina in diabetes mellitus has been a subject of controversy. In the intact cat retina, photoreceptor QO 2 was lower on average in subjects with diabetes than in healthy subjects, 47 but QO 2 has a strong positive correlation with choroidal PO 2 , and the choroidal PO 2 values tended to be lower in diabetic cats. Whether lower choroidal PO 2 is a general feature in diabetes could not be determined with the number of animals available in that study. In vitro studies in rabbits suggested that the QO 2 decreased in diabetes. 123, 124 In contrast, one study reported that QO 2 in diabetic rats 125 was greater. Little work has been done on the QO 2 of the inner retina. Tiedeman et al 12 found that retinal venous O 2 saturation was lower than normal in diabetic humans, and concluded on that basis that QO 2 of the inner retina must be greater in subjects with diabetes. If blood flow increased or was unchanged, this would be a reasonable conclusion, but blood flow was not measured in that study. Increased QO 2 is difficult to reconcile with capillary dropout and inner retinal damage.
On the theory that one of the major problems in diabetic retinopathy is lack of O 2 in the inner retina, therapies have been designed to improve the O 2 supply. Panretinal photocoagulation is effective in treating proliferative retinopathy. [126] [127] [128] [129] [130] Studies on animal models 46, [131] [132] [133] [134] and in humans 24 showed that PO 2 in the preretinal vitreous is higher over photocoagulated regions than over normal regions. These measurements provided little detail about O 2 gradients in the retina, and were obtained mainly during hyperoxia, which is not the condition in which diabetic retinopathy develops or progresses. Nevertheless, they provide some evidence that photocoagulation reduces the QO 2 of the photoreceptors, allowing more O 2 to diffuse from the choroid to the inner retina. 135, 136 At present, no treatment stops retinopathy apart from panretinal photocoagulation, but it seems reasonable that if early retinal circulatory changes preceding VEGF upregulation could be detected clinically, then interfering with leukocyte adhesion or using other pharmacological techniques to increase retinal blood flow might be effective in preventing retinopathy.
Retinopathy of Prematurity
Retinopathy of prematurity (ROP), previously known as retrolental fibroplasia, 137 develops in 3 distinct stages. 138 First, the retina of premature infants is exposed to excess O 2 as a result of breathing O 2 -enriched gas,which causes constriction and irreversible closure of retinal vessels and prevents new vessels from developing normally. 139, 140 As a result, hypoxia is thought to develop in the inner retina when the infant is returned to breathing air, and the extra supply of O 2 from the choroid is lost. Finally, this hypoxic con-dition induces vascularization to counteract the hypoxia, but for some reason this vascularization is abnormal. [140] [141] [142] The current therapy for prevention of the disease is generally to titrate the infant's blood to an adequate PaO 2 but to prevent systemic hyperoxia. Moderate supplemental O 2 with a target arterial saturation of 99% and a PaO 2 of less than 100 mm Hg was found to decrease prethreshold ROP. [143] [144] [145] Vitamin E supplementation may also be useful in decreasing the severity of ROP, [146] [147] [148] possibly by minimizing auto-oxidative reactions that arrest the growth of normal blood vessels. 148 Other therapies, such as gradual reduction in O 2 level (oxygen weaning) appear less promising. [149] [150] [151] Mechanistically, the disease is not as straightforward as the above discussion would suggest. As in diabetic retinopathy, it has been impossible to determine exactly what the oxygenation status of the human retina is at any time during the disease progression, and difficult even in the animal models. Ernest and Goldstick 152 used O 2 microelectrodes in the vitreous humor of kittens after O 2 supplementation (80%-90% O 2 ) and found that preretinal PO 2 over the avascular retina was close to 0 mm Hg, but normal over the vascular retina. These remain the only direct measurements of PO 2 in an ROP model. More recently, attention has shifted to a rodent model of ROP called ischemia-induced or O 2 -induced retinopathy. 153, 154 Retinopathy is produced most effectively by a regimen that cycles the inspired gas between a relatively hyperoxic one and a relatively hypoxic or normoxic one for at least several days during retinal vascular maturation. 154 Surprisingly, well-controlled hyperoxia followed by normoxia produces ROP-like symptoms with less certainty than does O 2 cycling. In O 2 -induced retinopathy, some evidence from novel magnetic resonance imaging measurements suggests that hypoxia plays a role early in the disease. 155 Berkowitz and Penn 155 based this conclusion on a blunted response of retinal oxygenation to breathing of carbogen (a mixture of 95% O 2 and 5% carbon dioxide) in animals in which histological signs of the disease developed, rather than a direct demonstration of tissue hypoxia.
As in diabetic retinopathy, it is thought that hypoxia does not directly affect vessel growth, but instead influences the production of angiogenic factors in the retina, 138 with the probable involvement of hypoxiainducible factor 1 as an intermediate. 156
Vascular Occlusive Diseases
Work on complete ocular ischemia, produced in general with elevation of IOP, and work on the effects of anoxia on the retina in vitro have a long history. Although they are relevant to ocular ischemic syndrome, in which the retinal and choroidal circulations are compromised by carotid artery obstruction, 157 they will not be reviewed herein. Of more interest from a clinical standpoint is the role of O 2 in central and branch venous and arterial occlusions of the retinal circulation. Experimental venous occlusion in pigs leads to decreased inner retinal PO 2, which can be followed by neovascularization. 158 Work on cats shows that retinal arterial occlusion makes the entire inner retina anoxic, 57, 61 and this causes a rapid failure of the ERG b wave (REPRINTED) ARCH OPHTHALMOL / VOL 121, APR 2003 WWW.ARCHOPHTHALMOL.COM 552 in cats and monkeys. 57, 159, 160 Even when the animal breathes air, the retina is reasonably tolerant to occlusion, surviving episodes of 100 to 120 minutes with full recovery of the ERG 159, 160 after the occlusion is reversed. Several studies have shown that retinal oxygenation can be partially or completely restored during the arterial occlusion by making animals hyperoxic. 57, 61, 161, 162 It is clear from O 2 profiles that this effect relies on an increased O 2 supply from the choroid during hyperoxia. Corroborating the importance of O 2 as the limiting factor during occlusion are a few studies that have used a model of total ischemia. Anderson and Saltzman 2 have shown that if human subjects breathed O 2 before IOP elevation, their vision was sustained longer than if they breathed air. Blair and coworkers 163 have shown that perfusing the vitreous with an oxygenated solution after total occlusion can maintain the structural integrity of the retina and the ERG. Despite this positive experimental data, the clinical experience with hyperoxia has been mixed, with only a few studies recommending hyperoxia as a treatment for vascular occlusion. 164, 165 Unfortunately, most clinical attempts to provide hyperoxia during occlusion have not adequately considered that it must be provided for large blocks of time and as soon as possible because O 2 is not stored and is used so rapidly. In addition, there have been two fears of using hyperoxic therapy. First, hyperoxia constricts retinal vessels, and this might impede the clearance of emboli. This may be an unnecessary concern, because the inner retina is acidic during occlusion (Gulnur Birol, PhD, N.D.W.-W., Ewa Budzynski, MS, and R.A.L., unpublished data, October 2002), which would tend to counteract hyperoxic vasoconstriction. In addition, carbon dioxide can be added to the inspired gas to induce vasodilation. 164, 165 Second, extended O 2 breathing can be toxic, but this should not prevent hyperoxic therapy, because it is possible to breathe 60% to 70% O 2 for hours without toxic effects. 166 
Other Diseases
Oxygen undoubtedly plays a role in other diseases. Several studies report that cystoid macular edema can be ameliorated by hyperbaric O 2 therapy. [167] [168] [169] [170] No clear theoretical reason for this exists. Depending on the mechanism of this effect, hyperoxia at normal atmospheric pressure may do just as well. This has not been tested, but should be, because it would allow application of the therapy to more patients.
Oxygen is likely to play a role in the dramatic vasoattenuation of the retinal circulation that is associated with photoreceptor degenerations in humans and animals. 171 This role can be understood on the basis of the normal gradients. When photoreceptors are lost, O 2 derived from the choroid that was once used by photoreceptors now diffuses all the way to the inner retina. 172, 173 In addition to the reduced size of the major vessels, capillaries in the inner retina are permanently lost 174 in animals with photoreceptor degeneration. This capillary loss can be prevented by maintaining the animals under hypoxic conditions, which probably reduce the flux of O 2 from the choroid to the inner retina. Evidence also exists that O 2 can modulate the survival of photoreceptors early in the Royal College of Surgeons rat model of reti-nal degeneration. Hyperoxia is protective at early stages, whereas hypoxia induces death of photoreceptors. 175 Upregulation of basic fibroblast growth factor by hypoxia is not sufficient to prevent photoreceptor death, 176 and later stages of the photoreceptor loss may not be caused by hypoxia.
Although a focus on mechanical causes of ganglion cell loss in glaucoma continues, many lines of evidence indicate that reduced ocular blood flow, and by implication reduced O 2 , is a contributing factor in the retinal damage in glaucoma. 177, 178 This is a complex area in which most of the evidence is indirect, but support for a vascular hypothesis continues to accumulate. First, hyperbaric O 2 , which does not change IOP, can improve visual fields in glaucomatous subjects. 179 Second, photocoagulation, which destroys photoreceptors and presumably increases the inner retinal O 2 supply from the choroid, promotes survival of ganglion cells in glaucomatous monkeys. 180 Third, cones, which should not be affected directly by mechanical stresses at the optic nerve, are swollen in eyes of humans with glaucoma and in primates with experimental glaucoma. 181 Finally, systemic vascular variables, which have been known to be risk factors for glaucoma, help predict the degree of visual dysfunction in glaucoma. 182 Oxygen may also play a role in vision loss in retinal detachment. A recent argument has been made on a theoretical basis that hyperoxia may be useful in preventing photoreceptor damage. 41 Detachment separates the inner segments from their O 2 supply, and although no consuming tissue is found under the retina, the increased distance reduces the flux of O 2 from the choroid to the photoreceptor inner segments. Hyperoxia should restore this flux, at least for detachments of moderate height, because increased choroidal PO 2 can compensate for the increased distance. For large detachments, the photoreceptors may benefit more from increased amounts of O 2 in the retinal circulation than in the choroidal circulation. The protective effect of hyperoxia on detached photoreceptors has been shown experimentally in cats, in which hyperoxia was able to save photoreceptors and prevent the activation of retinal glia normally caused by detachment. 183, 184 
CONCLUSIONS
Most of the important features of normal retinal oxygenation are now known, and the status of retinal oxygenation in some prevalent diseases has been partially elucidated. Tissue hypoxia is believed to be important in regulating vascular growth factors, particularly in the vasoproliferation observed in diabetes mellitus and ROP. Hypoxia is also involved in the loss of photoreceptors during a retinal detachment and the loss of inner retinal neurons in retinal arterial occlusions. Evidence is emerging that hypoxia may damage photoreceptors and possibly other cells in glaucoma, and that O 2 modulates the survival of photoreceptors in photoreceptor degenerations. One of the most interesting aspects of retinal oxygenation is the important metabolic role of the choroidal circulation. Lack of regulation of the choroid by O 2 may be detrimental to the photoreceptors under conditions when choroidal PO 2 or choroidal blood flow decrease (eg, glau-(REPRINTED) ARCH OPHTHALMOL / VOL 121, APR 2003 coma), but this same lack of regulation provides an opportunity to use the choroid therapeutically in treating cystoid macular edema, retinal arterial occlusions, and retinal detachment. Oxygen therapy only has a chance of working if it is sustained, however, and this has generally not been the mode in which it has been used.
The difficulty of measuring O 2 intraretinally in humans or in animal models of human diseases has prevented a more complete understanding of the role of O 2 in retinal diseases. Measuring retinal O 2 would be far better than measuring blood flow, because tissue PO 2 is the variable that is directly relevant to metabolism and presumably to visual function. Noninvasive measurements have been difficult, because of the spatial heterogeneity of PO 2 in the retina and the difficulty of accessing the choroid, but these techniques are important and need to be developed. Development of noninvasive optical techniques would allow one to study the timing of hypoxia with respect to biochemical and histological changes, and would serve as a way to follow disease progression and evaluate treatments. January 4, 2002;  final revision received November 15, 2002; accepted December 6, 2002. This study was supported by grant EY05034 from the National Institutes of Health, Bethesda, Md.
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